NIH-funded research NIH-funded research

Understanding how reactive oxygen species affect cell signaling

Official title: Molecular mechanisms of cellular redox signaling

Funded at Cornell University · NIH-11004686 · Data updated 2026-11-12

This study is looking at how certain molecules in our cells can both cause damage and help activate helpful processes, which could lead to better ways to treat conditions related to cell stress and injury.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCornell University
NIH-funded
Lab location1 site (Ithaca, United States)
Project startJanuary 1, 2024
Project endNovember 30, 2028
Funding year2025
Award (this year)$344,250
NIH project number5R35GM152166-02
Project IDNIH-11004686 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals with conditions related to oxidative stress, such as aging-related disorders or chronic diseases.

Less likely to help

Patients with conditions unrelated to oxidative stress or cellular signaling may not receive any benefit from this research.

What this research studies

This research investigates the dual roles of reactive oxygen species (ROS) in cellular processes, focusing on how they can both damage cells and activate beneficial signaling pathways. The study aims to identify specific pathways influenced by ROS through the modification of proteins, particularly cysteine and methionine residues. By characterizing these redox-signaling components, the research seeks to enhance our understanding of how cells manage oxidative stress and develop potential therapeutic strategies. Patients may benefit from insights gained about cellular responses to stress and injury.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic approaches for diseases associated with oxidative stress and cellular damage.

How similar studies have gone: Other research has shown promise in understanding redox signaling pathways, indicating that this approach could yield significant insights.

Where this research is happening

  • Cornell University
    Ithaca, United States
    Active

Researchers

  • Principal investigator: Sevier, Carolyn S — Cornell University
  • Study coordinator: Sevier, Carolyn S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.